Comparison

Rift Valley Fever Virus Nucleocapsid Peptide

Item no. PRS-7413P-0.05mg
Manufacturer ProSci
Amount 0.05 mg
Category
Type Peptides
Format Liquid
Applications Blocking
Specific against other
Citations Morrill JC and McClain DJ. Epidemiology and pathogenesis of the Rift Valley fever and other phleboviruses, p. 281-93 in H Fraenkel-Conrat and RR Wagner (ed.) The viruses. Plenum Press, New York, NY.
NCBI NP
ECLASS 10.1 32160409
ECLASS 11.0 32160409
UNSPSC 12352202
Available
Manufacturer - Applications
The peptide is used for blocking the activity of Rift Valley Fever Virus Nucleocapsid antibody (catalog number 7413). It usually blocks the antibody activity completely by incubating the peptide with equal volume of antibody for 30 min at 37°C.
Storage Conditions
Store Rift Valley Fever Virus Nucleocapsid peptide at -20°C, stable for one year.
Peptide Name
Rift Valley Fever Virus Nucleocapsid Peptide
Peptide aa Location
17 amino acids near the center of Rift Valley Fever Virus.
Protein Gi #
302596926
Concentration
200 ug/mL
Buffer
PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin and 0.02% sodium azide
NCBI Official Name
NP nucleocapsid [ Rift Valley fever virus ]
NCBI Organism
Rift Valley fever virus
Disclaimer
This product is for research use only.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 0.05 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close